Dr Diana Isaacs Surveys Emerging Diabetes, Obesity, and Cardiometabolic Treatment Landscape
April 24th 2024Diana Isaacs, PharmD, chair of a recent Institute for Value-Based Medicine® event hosted in conjunction with Cleveland Clinic, details the up-and-coming therapies impacting the scope of treatment in diabetes, obesity, and cardiometabolic health, as well as their associated challenges.
Watch
Dr Robert Zimmerman Discusses Challenges, Adverse Effects of GLP-1 and Multi-Agonist Therapies
April 23rd 2024Robert Zimmerman, MD, discussed the adverse side effects associated with glucagon-like peptide-1 (GLP1) and multi-agonist therapies, as well as explored the challenges in developing these interventions.
Watch
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Dr Kevin Malloy Discusses the Evolution of GLP-1 Receptor Agonists
April 15th 2024Kevin Malloy, PharmD, BCPS, BC-ADM, CDCES, Cleveland Clinic, discusses how GLP-1 receptor agonists have evolved in the treatment landscape of diabetes and obesity at an Institute for Value-Based Medicine® event hosted in conjunction with Cleveland Clinic.
Watch
Conference Chair Dr Daniel Ontaneda Previews ACTRIMS Forum 2024
February 23rd 2024Daniel Ontaneda, MD, PhD, Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2024 chair, discussed what attendees can expect at this year's meeting, as well as how the theme of "Breaking Barriers in MS" will be implemented.
Watch
Dr Sudipto Mukherjee: Rethinking Clinical Management for Patients With ISM
February 22nd 2024Population-level data highlight varied risk profiles among patients with indolent systemic mastocytosis (ISM), highlighting the need for individualized treatment approaches, according to Sudipto Mukherjee, MD, PhD, MPH, a physician in the department of hematology and medical oncology at Cleveland Clinic.
Watch
Advancements in Diabetes Technology: Coverage, Challenges, and Pregnancy Considerations
February 15th 2024Expert interviews highlight advancements and challenges in diabetes care technology, including automated insulin delivery systems and continuous glucose monitors, as well as improvements in insurance coverage.
Read More
Dr Sudipto Mukherjee Discusses Survival Outcomes Data in US Patients With ISM
January 30th 2024Sudipto Mukherjee, MD, PhD, MPH, hematology and medical oncology, Cleveland Clinic, suggests that some patients with indolent systemic mastocytosis (ISM) may be progressing at a faster rate than expected, and will need to be monitored and started on appropriate therapies.
Watch
Dr Brian Mullen Highlights Patient Education, Cost-Effectiveness Strategies in Digital Health
October 30th 2023Brian Mullen, PhD, head of innovation and product at The Clinic by Cleveland Clinic, shares his expertise in providing easy-to-use digital health platforms for patients, while maintaining the cost-effectiveness of these innovations.
Watch
Dr Brian Mullen Shares Digital Health Advancements at The Clinic by Cleveland Clinic
October 19th 2023Brian Mullen, PhD, head of innovation and product at The Clinic by Cleveland Clinic, discusses the implementation of digital health tools and strategies made by The Clinic and what these improvements mean for its patients.
Watch
Dr Milind Desai on VALOR-HCM: Primary and Secondary Effects Are Sustained While on Mavacamten
September 16th 2023Secondary effects not only improved past 16 weeks, but showed a sustained improvement at week 56 of mavacamten, said Milind Desai, MD, MBA, director of the Hypertrophic Cardiomyopathy Center and vice chair of education at the Heart, Vascular & Thoracic Institute, Cleveland Clinic.
Watch
Dr Milind Desai Highlights New Findings From VALOR-HCM Trial
September 5th 2023After 16 weeks on placebo, patients in the control group were invited to start mavacamten alongside the treatment group, explained Milind Desai, MD, MBA, director of the Hypertrophic Cardiomyopathy Center and vice chair of education at the Heart, Vascular & Thoracic Institute, Cleveland Clinic.
Watch
Dr Roxana Siles: QOL Improves Greatly From Effective Chronic Cough Treatment
June 14th 2022Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, address the impact of effective treatments of chronic cough on patient quality of life (QOL).
Watch
Dr Roxana Siles: We Need to Address the Needs of Patients With Refractory/Unexplained Cough
May 22nd 2022Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, discusses the important need for chronic cough therapies and what issues with current treatments should be addressed by next-generation medications.
Watch
Many Patients With ESKD Are Not Placed on Kidney Transplant Waitlist Despite Eligibility
June 17th 2021Eligible patients who are not waitlisted for kidney transplants lose profound opportunities and are subject to racial and socioeconomic disparities regarding waitlist placement, a study showed.
Read More
How Do Education, Social Support Affect PAP Adherence in Patients With OSA?
May 7th 2021The group-based Sleep Apnea Management clinic at Cleveland Clinic's Sleep Disorders Center increased criteria-met adherence to positive airway pressure (PAP) therapy by 20% in patients with obstructive sleep apnea (OSA).
Read More
The Role of SGLT-2 Inhibitors in Heart Failure: A Roundtable Discussion
September 18th 2020The American Journal of Managed Care® recently hosted a Peer Exchange that featured discussion among a panel of expert cardiologists and managed care decision makers regarding how cardiovascular outcome trial results are impacting the use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in patients with heart failure and how these drugs are shaping heart failure outcomes for patients. Panelists were Nihar R. Desai, MD, MPH, assistant professor of medicine in the cardiovascular medicine section of the Yale School of Medicine and investigator in the Center for Outcomes Research and Evaluation in New Haven, Connecticut; Jaime Murillo, MD, national senior director of cardiology at UnitedHealthcare in Fort Lauderdale, Florida; and Steven Nissen, MD, chief academic officer of the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at the Cleveland Clinic in Cleveland, Ohio. The moderator was Neil B. Minkoff, MD, chief medical officer of Coeus Consulting Group in Sudbury, Massachusetts.
Read More